Plunkett Research Online: BioSpecifics Technologies Corp

BIOSPECIFICS TECHNOLOGIES CORP (BSTC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of injectable collagenase clostridium histolyticum (CCH) for multiple indications. The firm has a development and license agreement with Endo International plc for injectable collagenase, named XIAFLEX, for c.....



BioSpecifics Technologies Corp
Ticker: BSTC
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 516-593-7000
Fax: 516-593-7039
Address: 35 Wilbur Street
Lynbrook, NY 11563 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Thomas WegmanCEO/CFO/Chief Accounting Officer/Director/President
Toby WegmanDirector
See More
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of injectable collagenase clostridium histolyticum (CCH) for multiple indications. The firm has a development and license agreement with Endo International plc for injectable collagenase, named XIAFLEX, for c.....See More See More

Auditor: EisnerAmper LLP
Legal Advisor: Bingham McCutchen LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
XIAFLEX
XIAPEX
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: